World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility

ResearchWorks/Manakin Repository

Search ResearchWorks


Advanced Search

Browse

My Account

Statistics

Related Information

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility

Show simple item record

dc.contributor.author Bacon, David J. en_US
dc.contributor.author Jambou, Ronan en_US
dc.contributor.author Fandeur, Thierry en_US
dc.contributor.author Le Bras, Jacques en_US
dc.contributor.author Wongsrichanalai, Chansuda en_US
dc.contributor.author Fukuda, Mark M. en_US
dc.contributor.author Ringwald, Pascal en_US
dc.contributor.author Sibley, Carol Hopkins en_US
dc.contributor.author Kyle, Dennis E. en_US
dc.date.accessioned 2010-05-06T20:05:55Z
dc.date.available 2010-05-06T20:05:55Z
dc.date.issued 2007 en_US
dc.identifier.citation Bacon D, Jambou R, Fandeur T, et al. World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility. Malaria Journal. 2007;6(1):120. en_US
dc.identifier.other 10.1186/1475-2875-6-120 en_US
dc.identifier.uri http://www.malariajournal.com/content/6/1/120 en_US
dc.identifier.uri http://hdl.handle.net/1773/15843
dc.description.abstract Intrinsic resistance of Plasmodium falciparum is clearly a major determinant of the clinical failure of antimalarial drugs. However, complex interactions between the host, the parasite and the drug obscure the ability to define parasite drug resistance in vivo. The in vitro antimalarial drug susceptibility assay determines ex-vivo growth of parasite in the presence of serial drug concentrations and, thus, eliminates host effects, such as drug metabolism and immunity. Although the sensitivity of the parasite to various antimalarials provided by such a test provides an important indicator of intrinsic parasite susceptibility, there are fundamental methodological issues that undermine comparison of in vitro susceptibility both between laboratories and within a single laboratory over time. A network of laboratories is proposed that will agree on the basic parameters of the in vitro test and associated measures of quality control. The aim of the network would be to establish baseline values of sensitivity to commonly used antimalarial agents from key regions of the world, and create a global database, linked to clinical, molecular and pharmacology databases, to support active surveillance to monitor temporal trends in parasite susceptibility. Such a network would facilitate the rapid detection of strains with novel antimalarial resistance profiles and investigate suitable alternative treatments with retained efficacy. en_US
dc.description.sponsorship Some of this work was supported by funds provided by the Department of Defense-Global Emerging Infectious System (DoD-GEIS) under the unit number 847705.82000.256B, B0016. en_US
dc.language.iso en_US en_US
dc.title World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility en_US
dc.type Article en_US


Files in this item

Files Size Format View
1475-2875-6-120.pdf 449.0Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record